The company has completed its FDA submission for the system and inked a deal with UAE-based healthcare provider Burjeel Holdings to deploy the system in its facilities.

Omar M. Abuattieh, a student attending the Ernest Mario School of Pharmacy at Rutgers University-New Brunswick, has been ...

Merck is growing pharma sales and expanding margins, led by strong KEYTRUDA performance and cost discipline. Read more about ...

The city of Houston will need to find a new source of funding for building a 20,000-square-foot lab near the Texas Medical ...

He is the head of HHS, and yet he continues to spout untested, unproven therapies and has only given a very lukewarm ...

A federal website that used to feature information on vaccines, testing and treatment for COVID-19 has been transformed into ...

The move comes after the Trump administration slashed billions in Covid funding on the grounds that “the pandemic is over.” ...

The site has been directed to a new landing page that argues for the theory that COVID-19 originated from a mistaken lab leak in Wuhan, China.

Milan Kalawadia, CEO, North America, at Dr. Reddy’s Laboratories, goes inside the company’s new growth initiatives—and ...

"Unilever will be giving an update on first quarter trading next week, with investors eager to get more insight into the company's evolving strategy under its new CEO, Fernando Fernandez," Hargreaves ...

Cutaneous immune-related adverse events that develop after immune checkpoint inhibitor therapy become chronic in nearly ...

The PD-L1 IHC 22C3 PharmDx (Code SK006) assay is now certified for use to aid treatment decisions for patients with gastric or gastroesophageal junction adenocarcinoma.